Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live longer and better destroy cancer cells in a mouse model of melanoma compared ...

Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

expression score and immune infiltration score (IIS) were the lowest among ACC patients, compared with other cancer types. For 61 primary cases, the locoregional recurrence-free survival (LRRFS) was ...

Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live ...

This can have serious therapeutic consequences, as cancer stem cells are resistant to most forms of chemotherapy (13). In addition, senescent cells secrete a multitude of SASP factors that can induce ...

Dr. Won Jin Ho presented a talk as part of the Immunology Neighborhood Seminar on “Overcoming the tumor immune ...

D tumoroid models transform cancer research, accurately reflecting tumor biology and enabling effective drug testing and ...

To create one of the most advanced immunotherapies in cancer, CAR-T cell therapies, scientists engineer immune T cells to carry a synthetic protein on their surfaces. This protein, called the ...

Researchers found that radiotherapy may reduce immune cells in the tumor-immune microenvironment, potentially impacting ...